Search research articles
Contact Us
Filters
Showing results (61-70 of 132) with videos related to
Page
of 14
Sort By:
Leukemia & Lymphoma
|
October 31, 2006
Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome
Alberto J Montero, Zeev Estrov, Emil J Freireich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 18, 2017
Reply to Á. Benedict et al
Christine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2017
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma
Christine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
The Breast Journal
|
April 21, 2021
Retrospective study of clinical outcomes in patients with Stage IV HER2+ breast cancer undergoing primary breast surgery
Arslan Babar, Zahraa Al-Hilli, Fahrettin Covut, et al.
Breast Cancer Research and Treatment
|
January 20, 2026
Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study
Nickolas Stabellini, Jasskiran Kaur, Cynthia Owusu, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
January 20, 2010
Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma
Relin Yang, Michael C Cheung, Margaret M Byrne, et al.
The American Journal of Managed Care
|
April 14, 2025
Comparing breast cancer treatment outcomes between fee-for-service and Medicare Advantage
Galen Shearn-Nance, Rishi R Sachdev, Long Vu, et al.
Cancer Medicine
|
December 15, 2018
Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data
Askal A Ali, Rima Tawk, Hong Xiao, et al.
Cancer Immunology, Immunotherapy : CII
|
May 1, 2008
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C Marcela Diaz-Montero, Mohamed Labib Salem, Michael I Nishimura, et al.
BMC Cancer
|
December 7, 2007
Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
John Hayslip, Uzair Chaudhary, Mark Green, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 132) with videos related to
Sort By:
Page
of 14
Leukemia & Lymphoma
|
October 31, 2006
Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome
Alberto J Montero, Zeev Estrov, Emil J Freireich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 18, 2017
Reply to Á. Benedict et al
Christine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2017
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma
Christine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
The Breast Journal
|
April 21, 2021
Retrospective study of clinical outcomes in patients with Stage IV HER2+ breast cancer undergoing primary breast surgery
Arslan Babar, Zahraa Al-Hilli, Fahrettin Covut, et al.
Breast Cancer Research and Treatment
|
January 20, 2026
Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study
Nickolas Stabellini, Jasskiran Kaur, Cynthia Owusu, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
January 20, 2010
Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma
Relin Yang, Michael C Cheung, Margaret M Byrne, et al.
The American Journal of Managed Care
|
April 14, 2025
Comparing breast cancer treatment outcomes between fee-for-service and Medicare Advantage
Galen Shearn-Nance, Rishi R Sachdev, Long Vu, et al.
Cancer Medicine
|
December 15, 2018
Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data
Askal A Ali, Rima Tawk, Hong Xiao, et al.
Cancer Immunology, Immunotherapy : CII
|
May 1, 2008
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C Marcela Diaz-Montero, Mohamed Labib Salem, Michael I Nishimura, et al.
BMC Cancer
|
December 7, 2007
Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
John Hayslip, Uzair Chaudhary, Mark Green, et al.
Page
of 14